cdx-011
Showing 1 - 2 of 2
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer Trial in Worldwide (CDX-011, Capecitabine)
Completed
- Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
- CDX-011
- Capecitabine
-
Birmingham, Alabama
- +139 more
Mar 6, 2019
Breast Cancer Trial in United States (CDX-011, "Investigator's Choice" chemo)
Completed
- Breast Cancer
- CDX-011
- "Investigator's Choice" chemotherapy
-
Birmingham, Alabama
- +23 more
Jun 26, 2017